{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:27:03Z","timestamp":1791350823836,"version":"4.3.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.kint.2024.07.006","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T09:11:00Z","timestamp":1724145060000},"page":"359-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chemical chaperones to the rescue of Alport syndrome?"],"prefix":"10.1016","volume":"106","author":[{"given":"Roberto M.","family":"Vanacore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2024.07.006_bib1","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMra022296","article-title":"Alport's syndrome, Goodpasture's syndrome, and type IV collagen","volume":"348","author":"Hudson","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2024.07.006_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.kint.2024.04.015","article-title":"Tauroursodeoxycholic acid ameliorates renal injury induced by COL4A3 mutation","volume":"106","author":"Yu","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.07.006_bib3","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1101\/gad.10.23.2981","article-title":"Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome","volume":"10","author":"Cosgrove","year":"1996","journal-title":"Genes Dev"},{"key":"10.1016\/j.kint.2024.07.006_bib4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1083\/jcb.135.5.1403","article-title":"Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome","volume":"135","author":"Miner","year":"1996","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.kint.2024.07.006_bib5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.chembiol.2018.02.003","article-title":"A\u00a0split-luciferase-based trimer formation assay as a high-throughput screening platform for therapeutics in Alport syndrome","volume":"25","author":"Omachi","year":"2018","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.kint.2024.07.006_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbplus.2020.100053","article-title":"A\u00a0glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport\u00a0syndrome","volume":"9","author":"Odiatis","year":"2021","journal-title":"Matrix Biol Plus"},{"key":"10.1016\/j.kint.2024.07.006_bib7","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3390\/cells8121471","article-title":"Tauroursodeoxycholate-bile acid with chaperoning activity: molecular and cellular effects and therapeutic perspectives","volume":"8","author":"Kusaczuk","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.kint.2024.07.006_bib8","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.034157","article-title":"Use of sodium 4-phenylbutyrate to define therapeutic parameters for reducing intracerebral hemorrhage and myopathy in Col4a1 mutant mice","volume":"11","author":"Hayashi","year":"2018","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.kint.2024.07.006_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/jbmr.4501","article-title":"4-PBA treatment improves bone phenotypes in the Aga2 mouse model of osteogenesis imperfecta","volume":"37","author":"Duran","year":"2022","journal-title":"J\u00a0Bone Miner Res"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824004769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824004769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T09:17:23Z","timestamp":1724145443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253824004769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0085253824004769"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2024.07.006","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical chaperones to the rescue of Alport syndrome?","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.04.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}